University College Dublin logo
ALL PROFILES

Professor

Michael Keane

Full Professor Of Medicine And Therapeutics, Head Of School
School of Medicine
University College Dublin, School of Medicine, St Vincent's Hospital Elm Park Dublin 4

RESEARCH INTERESTS

GRANT SUPPORT Current SFI PI Award, Principal Investigator, IL-13 receptor in lung injury and remodelling. €1,206,361 direct costs Recent NIH RO1 HL080206, Co-Investigator, The role of chemokines during lung allograft rejection. 8/1/05-7/31/09. $1,250,000 direct costs NIH RO1 AR055075, Principal Investigator, Cytokines as predictors of disease progression in scleroderma lung disease. 9/1/06-8/31/10. $880,000 direct costs (Tansferrred to another PI upon my leaving UCLA) NIH P50 HL67655 Principal investigator, Project 2 (35% effort), TH2 cytokines and CC chemokines in Pulmonary Fibrosis, 9/1/01-8/31/06 ($904,902 direct costs). Sunol Molecular Corporation, Principal Investigator, The safety, Pharmacokinetics and Physiological Effects of Sunol-cH36 in patients with acute lung injury/acute respiratory distress syndrome. 2/1/2005-1/31/2007. NIH KO8 HL03906, Principal Investigator (80% effort), "Chemokines regulate angiogenesis in pulmonary fibrosis"; 2/1/99-1/31/2004 ($620,000 direct costs) Council on Research of the Academic Senate at UCLA, Assistant Professor Initiative, "CC chemokines and TH2 cytokines in Pulmonary Fibrosis", 11/1/00-6/30/01 ($2,000) American Lung Association Dalsemer Research Scholar Award, "TH2 cytokines and CC chemokines in Pulmonary Fibrosis", 7/1/01-6/30/03 ($49, 970).